Stocks and Finance

Allos Therapeutics

Allos Therapeutics 4/5/2012

07:29 : Nevada company buying Allos Therapeutics - Allos Therapeutics Inc. of Westminster announced Thursday it’s being acquired by Spectrum Pharmaceuticals in a deal worth at least $206 million. Allos (Nasdaq: ALTH) is selling for $1.82 a share ...
Source : bizjournals-com

Allos Therapeutics 1/20/2012

09:02 : Allos Therapeutics (ALTH) -19.3% premarket after receiving a negative ... - Allos Therapeutics (ALTH) -19.3% premarket after receiving a negative opinion from European regulators on its Folotyn treatment for patients with peripheral T-cell lymphoma. The company says it plans to submit a request for re-examination ...
Source : seekingalpha-com

Allos Therapeutics 7/20/2011

15:20 : AMAG Pharmaceuticals, Inc. (AMAG) to Merge with Allos Therapeutics, Resulti - AMAG Pharmaceuticals, well known as the biopharmaceutical company behind the FERAHEME® injection for treating iron deficiency anemia in adult chronic kidney disease and Allos Therapeutics, developers ...
Source : ibtimes-com
actualidad Allos Therapeutics -


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts